The impact of COVID- 19 on the healthcare sector

03/30/21 • 22 min

Tune into this episode of PwC's Next in Health to hear Health Research Institute leader, Benjamin Isgur, and Health Research Institute Regulatory Center leader, Trine Tsouderos, discuss how COVID-19 is changing the healthcare industry, including:

COVID-19 vaccine hesitancy amongst healthcare workers
Impact of the Centers for Medicare & Medicaid Services (CMS) expansion on Medicare telehealth services
Medicare Payment Advisory Commission (MedPAC)'s findings on utilization and revenue disruption for providers
Uneven recovery of healthcare jobs amid pandemic

For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.

COVID-19 vaccine hesitancy amongst healthcare workers
Impact of the Centers for Medicare & Medicaid Services (CMS) expansion on Medicare telehealth services
Medicare Payment Advisory Commission (MedPAC)'s findings on utilization and revenue disruption for providers
Uneven recovery of healthcare jobs amid pandemic

For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.

Previous Episode

Pharmaceutical & Life Sciences Top Industry Issues

Tune into this episode of PwC's Next in Health to hear Health Research Institute Regulatory Center leader, Trine Tsouderos in discussion with PwC’s US Pharmaceutical and Life Sciences Leader, Glenn Hunzinger; on the top health industry issues of 2021; for pharmaceutical and life sciences companies, including:

Current industry landscape
Pharmaceutical & Life sciences deals outlook
Supply chain management and predictive technologies

For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.

Next Episode

Price Transparency 2021

Tune into this episode of PwC's Next in Health to hear Health Research Institute (HRI) leader, Benjamin Isgur, and HRI Regulatory Center leader, Trine Tsouderos in discussion with HRI's Crystal Yednak, on the new price transparency and impacts to healthcare stakeholders, including:

What do the new rules mean for providers and payers?
How will providers and payers use the newly available pricing data in upcoming negotiations?
How can consumers use this information?
What are the implications of these new rules on new entrants?

For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.